D. Western Therapeutics FY Loss Y632.00M Vs Loss Y1.29B

Dow Jones

02/13

    D. Western Therapeutics Institute Inc. (4576.TO) 
    Japan 
    Year Ended December 31 
GROUP              2025                   2024 
Revenue            Y387.00 mln     Y471.00 mln 
Operating Profit   (Y619.00 mln)   (Y1.21 bln) 
Pretax Profit      (Y630.00 mln)   (Y1.23 bln) 
Net Profit         (Y632.00 mln)   (Y1.29 bln) 
Per share 
  Earnings         (Y13.19)           (Y36.74) 
 
    Figures in parentheses are losses. 
 
    Results are based on Japanese accounting standards.

(END) Dow Jones Newswires

    D. Western Therapeutics Institute Inc. also released the following forecasts: 
GROUP                Year Ending 
                        Dec 2026 
Revenue              Y300.00 mln 
Operating Profit   (Y780.00 mln) 
Pretax Profit      (Y800.00 mln) 
Net Profit         (Y800.00 mln) 
Per share 
  Earnings              (Y14.75) 
 
    Figures in parentheses are losses. 
 
    Results are based on Japanese accounting standards.

This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.

(END) Dow Jones Newswires

February 13, 2026 01:39 ET (06:39 GMT)

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2611618073"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2611618073\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2611618073?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-13 14:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2611618073","market":"sg","top_or_hot":-1,"title":"D. Western Therapeutics FY Loss Y632.00M Vs Loss Y1.29B","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n    D. Western <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Institute Inc. (4576.TO) \n    Japan \n    Year Ended December 31 \nGROUP              2025                   2024 \nRevenue            Y387.00 mln     Y471.00 mln \nOperating Profit   (Y619.00 mln)   (Y1.21 bln) \nPretax Profit      (Y630.00 mln)   (Y1.23 bln) \nNet Profit         (Y632.00 mln)   (Y1.29 bln) \nPer share \n  Earnings         (Y13.19)           (Y36.74) \n \n    Figures in parentheses are losses. \n \n    Results are based on Japanese accounting standards. \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n</font><font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n    D. Western Therapeutics Institute Inc. also released the following forecasts: \nGROUP                Year Ending \n                        Dec 2026 \nRevenue              Y300.00 mln \nOperating Profit   (Y780.00 mln) \nPretax Profit      (Y800.00 mln) \nNet Profit         (Y800.00 mln) \nPer share \n  Earnings              (Y14.75) \n \n    Figures in parentheses are losses. \n \n    Results are based on Japanese accounting standards. \n</pre>\n<p>\n     This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com. \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 13, 2026 01:39 ET (06:39 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>D. Western Therapeutics FY Loss Y632.00M Vs Loss Y1.29B</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nD. Western Therapeutics FY Loss Y632.00M Vs Loss Y1.29B\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2026-02-13 14:39</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n    D. Western <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Institute Inc. (4576.TO) \n    Japan \n    Year Ended December 31 \nGROUP              2025                   2024 \nRevenue            Y387.00 mln     Y471.00 mln \nOperating Profit   (Y619.00 mln)   (Y1.21 bln) \nPretax Profit      (Y630.00 mln)   (Y1.23 bln) \nNet Profit         (Y632.00 mln)   (Y1.29 bln) \nPer share \n  Earnings         (Y13.19)           (Y36.74) \n \n    Figures in parentheses are losses. \n \n    Results are based on Japanese accounting standards. \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n</font><font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n    D. Western Therapeutics Institute Inc. also released the following forecasts: \nGROUP                Year Ending \n                        Dec 2026 \nRevenue              Y300.00 mln \nOperating Profit   (Y780.00 mln) \nPretax Profit      (Y800.00 mln) \nNet Profit         (Y800.00 mln) \nPer share \n  Earnings              (Y14.75) \n \n    Figures in parentheses are losses. \n \n    Results are based on Japanese accounting standards. \n</pre>\n<p>\n     This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com. \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 13, 2026 01:39 ET (06:39 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"製藥","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2611618073","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2611618073","pubTimestamp":1770964740,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","BK4168":"多种金属与采矿","BK4539":"次新股","LENZ":"Therapeutics","WRN":"西方铜金","BK4139":"生物科技"},"translate_title":"D.Western Therapeutics财年亏损Y632.00 M vs亏损Y1.29B","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WRN":1.5,"LENZ":1.5},"content_text":"D. Western Therapeutics Institute Inc. (4576.TO) \n    Japan \n    Year Ended December 31 \nGROUP              2025                   2024 \nRevenue            Y387.00 mln     Y471.00 mln \nOperating Profit   (Y619.00 mln)   (Y1.21 bln) \nPretax Profit      (Y630.00 mln)   (Y1.23 bln) \nNet Profit         (Y632.00 mln)   (Y1.29 bln) \nPer share \n  Earnings         (Y13.19)           (Y36.74) \n \n    Figures in parentheses are losses. \n \n    Results are based on Japanese accounting standards. \n\n\n  (END) Dow Jones Newswires\n\n\n\n    D. Western Therapeutics Institute Inc. also released the following forecasts: \nGROUP                Year Ending \n                        Dec 2026 \nRevenue              Y300.00 mln \nOperating Profit   (Y780.00 mln) \nPretax Profit      (Y800.00 mln) \nNet Profit         (Y800.00 mln) \nPer share \n  Earnings              (Y14.75) \n \n    Figures in parentheses are losses. \n \n    Results are based on Japanese accounting standards. \n\n\n     This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com. \n\n\n  (END) Dow Jones Newswires\n\n\n  February 13, 2026 01:39 ET (06:39 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}